HOME >> MEDICINE >> NEWS
Interventional cardiologists assemble in Orlando, Fla., for SCAI Annual Scientific Sessions

Angioplasty, stents, and other nonsurgical, catheter-based procedures used by interventional cardiologists to treat cardiovascular disease are increasingly replacing open-heart surgery. The Society for Cardiovascular Angiography and Interventions (SCAI) will bring together experts from around the world to share the latest news and information about stents, rapidly evolving therapies, and other breakthroughs in cardiovascular care. SCAI's Annual Scientific Sessions will convene Wednesday, May 9, through Saturday, May 12, 2007, in Orlando, Florida. SCAI is the worlds leading medical society for invasive and interventional cardiologists.

Highlights include

  1. Lectures by many of the worlds most distinguished physician-researchers on techniques and tools coming down the medical pipeline, including percutaneous aortic valve replacement, mitral valve repair, stem cell therapy, and treatment of migraine headache;
  2. New analyses on the causes of blood clots (thrombosis) in patients with drug-eluting stents, and how experts think this rare but dangerous side effect can be prevented;
  3. A critical look at some of the most hotly debated questions in cardiovascular care, such as whether 90 minutes is really an appropriate goal for door-to-balloon time and whether PCI is a viable option for patients with a blockage in the vitally important left main coronary artery;
  4. New findings on causes of, and treatment for, conditions such as the so-called Broken Heart Syndrome, Intestinal Angina, and holes in the heart
  5. Updates on new and rapidly evolving treatments of infants and young children with congenital heart disease; and
  6. Insights on the use of new imaging technologies for the early detection and treatment of coronary artery disease.


'"/>

Contact: Kathy Boyd David
kbdavid@scai.org
717-422-1181
Society for Cardiovascular Angiography and Interventions
1-May-2007


Page: 1

Related medicine news :

1. Report says cardiologists need guidelines for diagnosing, treating depression
2. SCAI scientific sessions attract world-renowned invasive/interventional cardiologists
3. New survey shows cardiologists aware of life-saving diet, yet failing to recommend it
4. Viral, gold nanoparticles can assemble themselves to potentially find and treat disease
5. AIUM hosts Third Annual Ultrasound Practice Forum
6. Pfizer Onocology press briefing scheduled during ASCO 2007 Annual Meeting
7. News from American Psychiatric Association 2007 Annual Meeting
8. SNMs 54th Annual Meeting speakers address state of molecular imaging/nuclear medicine technologies
9. Annual meeting of the National Academy of Sciences
10. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting
11. 2007 ARVO Annual Meeting draws spotlight on aging eye

Post Your Comments:
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... 04, 2015 FDA’s New Inspection Approach:, ... Webinar**, March 24, 2015 — 1:30 p.m. – 3:00 ... know within four hours of an inspection whether a ... on their “good” list, they’ll merely ask for reassurance ... is on the “bad” list, the manufacturer must get ...
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
(Date:3/4/2015)... York (PRWEB) March 04, 2015 More ... the cardiovascular risks potentially associated with low testosterone treatments ... (FDA) announced that it will now require manufacturers to ... their risk for heart attacks and strokes. In a ... the agency also stated that it was requiring testosterone ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)...  Results of the recent study, Results From ... Intra-Operative Positive Margin Detection , were presented as part ... Annual Miami Breast Cancer Conference last week. ... , MD, FACS, Professor of Surgery at the Sackler ... analysis of MarginProbe,s efficiency and accuracy when used consecutively ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
Cached News: